The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 29, 2021

Filed:

Feb. 21, 2018
Applicant:

Insulet Corporation, Acton, MA (US);

Inventors:

Maureen McCaffrey, Boston, MA (US);

Ian McLaughlin, Boxboro, MA (US);

Assignee:

INSULET CORPORATION, Acton, MA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61M 5/24 (2006.01); A61M 5/20 (2006.01); A61M 5/142 (2006.01); A61M 5/28 (2006.01); A61M 5/162 (2006.01); A61M 5/32 (2006.01); A61M 5/145 (2006.01); A61M 5/315 (2006.01); A61M 5/158 (2006.01);
U.S. Cl.
CPC ...
A61M 5/2466 (2013.01); A61M 5/14244 (2013.01); A61M 5/14248 (2013.01); A61M 5/162 (2013.01); A61M 5/2033 (2013.01); A61M 5/288 (2013.01); A61M 5/14566 (2013.01); A61M 5/3202 (2013.01); A61M 2005/14252 (2013.01); A61M 2005/1581 (2013.01); A61M 2005/1585 (2013.01); A61M 2005/208 (2013.01); A61M 2005/2474 (2013.01); A61M 2005/31518 (2013.01); A61M 2205/3386 (2013.01); A61M 2205/58 (2013.01); A61M 2205/82 (2013.01);
Abstract

Systems for piercing a septum of a drug delivery device is disclosed. The drug delivery device may include a needle conduit having an end and a drug container having a septum. The septum piercing mechanism may include a needle support operatively coupled to the needle conduit. The septum piercing mechanism may be movable from a first, unactivated configuration to a second, activated configuration. In the unactivated configuration, the septum seals an interior of the drug container from the end of the needle conduit. In the activated configuration, the end of the needle conduit pierces through the septum placing the needle conduit in fluid communication with the drug container. In one embodiment, activation may cause the needle support to move towards the drug container. In one embodiment, the needle support may be moved by a biasing member. Alternatively, in another embodiment, the needle support may be moved by a cam mechanism.


Find Patent Forward Citations

Loading…